Rev Esp Quimioter 2022;35(Suppl.3):51-53

New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections

MARIANA CHUMBITA, PATRICIA MONZO-GALLO, CARLOS LOPERA-MÁRMOL, TOMMASO FRANCESCO AIELLO, PEDRO PUERTA-ALCALDE, CAROLINA GARCIA-VIDAL

Published: 24 October 2022

http://www.doi.org/10.37201/req/s03.12.2022

Ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol belong to a novel generation of antibiotics that correspond with the β-lactam family. It is necessary to having new options in treating infections caused by Gram-negative, non-fermenting multidrug-resistant bacilli due to the significant increase in multidrug resistance in the last decades. Knowing the main characteristics of each drug is key for correct use.

Rev Esp Quimioter 2022; 35(Suppl.3):51-53 [Full-text PDF]